Congress Park Capital LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1730945 SARATOGA SPRINGS, NY

Position in CTMX

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$184,391

-$46,712 QoQ

Shares Held

49,171

0.0% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#99

of 178 holders

Holding Since

Mar 2020

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Congress Park Capital LLC holds $1,045,010 across 2 Biotechnology names. CTMX ranks #2 (17.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	HRTX	Heron Therapeutics, Inc. /De/	2,016,447	$860,619
2	CTMX	CytomX Therapeutics, Inc. This page	49,171	$184,391

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$184,391	49,171	0.0%	Shares	Sole	2026-07-14
2026-03-31	$231,103	49,171	-16.5%	Shares	Sole	2026-04-14
2025-12-31	$251,007	58,922	-43.3%	Shares	Sole	2026-01-14
2025-09-30	$331,511	103,922	+8.9%	Shares	Sole	2025-10-08
2025-06-30	$216,607	95,422	-85.8%	Shares	Sole	2025-07-11
2025-03-31	$428,464	673,686	-30.2%	Shares	Sole	2025-04-22
2024-12-31	$993,527	964,590	-20.7%	Shares	Sole	2025-01-15
2024-09-30	$1,434,889	1,216,008	+5.4%	Shares	Sole	2024-10-09
2024-06-30	$1,406,928	1,153,220	+393.3%	Shares	Sole	2024-07-12
2024-03-31	$509,684	233,800	-2.3%	Shares	Sole	2024-04-16
2023-12-31	$370,915	239,300	+112.8%	Shares	Sole	2024-01-19
2023-09-30	$145,060	112,450	+5.9%	Shares	Sole	2023-10-13
2023-06-30	$182,578	106,150	+5.9%	Shares	Sole	2023-07-14
2023-03-31	$151,302	100,200	+395.9%	Shares	Sole	2023-04-20
2021-03-31	$156,200	20,207	-21.7%	Shares	Sole	2021-04-19
2020-12-31	$169,035	25,807	-67.2%	Shares	Sole	2021-01-19
2020-09-30	$522,430	78,561	-9.0%	Shares	Sole	2020-10-20
2020-06-30	$718,970	86,311	-12.5%	Shares	Sole	2020-07-27
2020-03-31	$756,346	98,611	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.